Floxoptho KT Eye Drops
Floxoptho KT Eye Drops
Composition: Moxifloxacin Hydrochloride eq to Moxifloxacin 0.5% w/v + Ketorolac Tormethamine 0.4% w/v
Formulation: Eye Drops
Category: Antibiotic + NSAID
Packaging: 5ML
Eye Care Focus
Trusted Eye Solutions
Quality Eye Products
Floxoptho KT Eye Drops
Description
Therapy/Class: Antibiotic + NSAID
Mechanism of Action:
Ketorolac Tromethamine: A direct, non-selective COX inhibitor that prevents the conversion of arachidonic acid to endoperoxides. This halts the prostaglandin-mediated inflammatory cascade, significantly raising the nociceptive threshold (reducing pain) and preventing surgically induced miosis and cystoid macular edema.
Moxifloxacin: An 8-methoxy advanced generation fluoroquinolone that optimally inhibits both Topoisomerase II and Topoisomerase IV. The methoxy group at the C-8 position minimizes the selection of resistant mutants and broadens coverage against atypical, Gram-positive, and Gram-negative organisms in ocular infections.
Indications
Treatment of bacterial conjunctivitis caused by susceptible organisms
Superficial ocular bacterial infections as advised by the treating ophthalmologist
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Dosage & Administration
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
References
1. Flach AJ, et al. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 1987;103(4):479-486.
2. Bucci FA, et al. Ketorolac tromethamine in the reduction of ocular pain following refractive surgery. Cornea. 2008;27(8):919-922.
1. Stroman DW, et al. In vitro and in vivo efficacy of moxifloxacin and gatifloxacin against ocular pathogens. Surv Ophthalmol. 2005;50 Suppl 1:S16-24.
Warning: This information is only for the use of registered medical practitioners only.
